Sportradar: Focus On The Fundamentals

Sportradar is rated Buy on strong operating leverage and customer expansion, with 1Q26 revenue up 11% reported and 16% in constant currency, EBITDA up 12%, and free cash flow up 38% on IMG integration benefits. Management is guiding to 24% revenue growth and 35.5% EBITDA growth in FY26, supported by margin expansion and cross-selling synergies from the IMG acquisition. Long-term upside is also tied to entry into the growing prediction market.

Analysis

The market is likely still underappreciating how much of SRAD’s earnings power is now coming from mix and operating leverage rather than top-line acceleration alone. That matters because once integration synergies show up in cadence, the next leg is usually not linear: incremental EBITDA can re-rate faster than revenue as fixed tech, data, and distribution costs get absorbed. The implication is that the stock can work even if reported growth moderates, as long as conversion and cross-sell remain intact.

The competitive read-through is more interesting than the headline. A stronger SRAD raises the bar for smaller sports-data and media-tech vendors that compete on point solutions; customers will increasingly favor scaled platforms with better economics and broader product bundles. In parallel, the push into prediction markets could create a second-order network effect: access to new monetization rails may deepen partner stickiness and raise switching costs, but it also increases regulatory and platform-dependency risk if market access rules tighten or distribution partners change terms.

The main risk is timing mismatch. The market may extrapolate near-term margin expansion too aggressively, while the real upside from new verticals is a 12-24 month story with uneven monetization and possible legal friction. If the next quarter shows integration benefits but softer pipeline conversion or slower customer expansion, the stock could de-rate despite decent fundamentals because expectations are already elevated.

Consensus likely sees this as a clean quality compounder; what’s less appreciated is that M&A digestion often creates a window where execution is visibly strong before cross-sell revenue becomes fully attributable. That creates an opportunity to own the name into the next two reporting cycles, but not to chase it after extended multiple expansion. The better setup is to stay long for operating leverage while hedging the risk that prediction-market enthusiasm gets priced as if it were already a major earnings contributor.

Key Decisions for Investors

• Long SRAD on pullbacks over the next 2-6 weeks; target a 10-15% upside move if margin expansion stays ahead of guidance, with a stop if the market starts discounting integration fatigue or slower customer adds.
• Buy SRAD Jan-2027 call spreads to express the 12-24 month monetization path from prediction markets and IMG cross-sell, limiting premium burn if regulatory timing slips.
• Pair trade: long SRAD / short a smaller-cap sports-tech or data peer basket over 3-6 months to isolate operating leverage and scale advantages; thesis breaks if SRAD’s growth reaccelerates but peers show similar retention and pricing power.
• If SRAD gaps up sharply on momentum, take partial profits and roll into a collar or call spread, because the near-term setup is more about earnings quality than multiple expansion.
• Watch for a post-earnings confirmation trade: add on any evidence that free-cash-flow conversion and EBITDA margin guide higher again, since that would force estimate revisions and likely support another rerating over the next 1-2 quarters.